Learn More
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide (ATO) and thalidomide. Seven patients responded including one complete hematologic and cytogenetic response(More)
1 Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 2000; 14: 1743–1750. 2 Liu J,(More)
  • 1